Pacific Biosciences of California, Inc.Pacific Biosciences of California, Inc.Pacific Biosciences of California, Inc.

Pacific Biosciences of California, Inc.

No trades
See on Supercharts
Market capitalization
‪422.03 M‬USD
−1.21USD
‪−306.74 M‬USD
‪200.52 M‬USD
‪255.73 M‬
Beta (1Y)
3.17

About Pacific Biosciences of California, Inc.

CEO
Christian O. Henry
Website
Headquarters
Menlo Park
Employees (FY)
796
Founded
2000
ISIN
US69404D1081
FIGI
BBG000QKXH20
Pacific Biosciences of California, Inc. engages in the development, manufacture, and marketing of advanced sequencing solutions for genetic analysis. It operates through the following geographical segments: America, Europe, Middle East, and Africa, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of PACB is 1.55 USD — it has increased by 6.16% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Pacific Biosciences of California, Inc. stocks are traded under the ticker PACB.
Pacific Biosciences of California, Inc. is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
PACB stock is 16.76% volatile and has beta coefficient of 3.17. Check out the list of the most volatile stocks — is Pacific Biosciences of California, Inc. there?
One year price forecast for Pacific Biosciences of California, Inc. has a max estimate of 13.00 USD and a min estimate of 2.00 USD.
PACB earnings for the last quarter are −0.26 USD per share, whereas the estimation was −0.29 USD resulting in a 10.13% surprise. The estimated earnings for the next quarter are −0.29 USD per share. See more details about Pacific Biosciences of California, Inc. earnings.
Pacific Biosciences of California, Inc. revenue for the last quarter amounts to ‪55.69 M‬ USD despite the estimated figure of ‪48.76 M‬ USD. In the next quarter revenue is expected to reach ‪57.47 M‬ USD.
Yes, you can track Pacific Biosciences of California, Inc. financials in yearly and quarterly reports right on TradingView.
PACB stock has fallen by 53.17% compared to the previous week, the month change is a 56.94% fall, over the last year Pacific Biosciences of California, Inc. has showed a 85.75% decrease.
PACB net income for the last quarter is ‪−82.02 M‬ USD, while the quarter before that showed ‪−66.87 M‬ USD of net income which accounts for −22.65% change. Track more Pacific Biosciences of California, Inc. financial stats to get the full picture.
Today Pacific Biosciences of California, Inc. has the market capitalization of ‪422.03 M‬, it has increased by 1.17% over the last week.
No, PACB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PACB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Pacific Biosciences of California, Inc. stock right from TradingView charts — choose your broker and connect to your account.
PACB reached its all-time high on Feb 11, 2021 with the price of 53.69 USD, and its all-time low was 1.06 USD and was reached on Nov 15, 2012.
See other stocks reaching their highest and lowest prices.
As of Apr 20, 2024, the company has 796.00 employees. See our rating of the largest employees — is Pacific Biosciences of California, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Pacific Biosciences of California, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Pacific Biosciences of California, Inc. stock shows the strong sell signal. See more of Pacific Biosciences of California, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Pacific Biosciences of California, Inc. future price: according to them, PACB price has a max estimate of 13.00 USD and a min estimate of 2.00 USD. Read a more detailed Pacific Biosciences of California, Inc. forecast: see what analysts think of Pacific Biosciences of California, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Pacific Biosciences of California, Inc. EBITDA is ‪−277.67 M‬ USD, and current EBITDA margin is −138.48%. See more stats in Pacific Biosciences of California, Inc. financial statements.